Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RA2aTLB-GvyF89w0aO7qLw7b1KBqoAmyLVr_E1lkgHsxc#assertion>. }
Showing items 1 to 38 of
38
with 100 items per page.
- subject C0011777 "dexamethasone" assertion.
- object C0011777 "dexamethasone" assertion.
- subject C5203670 "COVID-19" assertion.
- subject C3887704 "treatment" assertion.
- subject C3538994 "treatment" assertion.
- subject C3161471 "treatment" assertion.
- subject C1705169 "treatment" assertion.
- subject C1533734 "treatment" assertion.
- subject C0087111 "treatment" assertion.
- subject C0020336 "hydroxychloroquine" assertion.
- object C0020336 "hydroxychloroquine" assertion.
- predicate select?q=TRIPLE_UID:oj2zt5xw-TRIPLE-ABSTRACT-2 "have" assertion.
- object C4521542 "release" assertion.
- object C3714741 "data" assertion.
- object C3245505 "potential" assertion.
- object C3245479 "data" assertion.
- object C2004454 "RECOVERY" assertion.
- object C1963578 "release" assertion.
- object C1555688 "RECOVERY" assertion.
- object C1546944 "significant" assertion.
- object C1511726 "data" assertion.
- object C1279919 "early" assertion.
- object C0750502 "significant" assertion.
- object C0680255 "release" assertion.
- object C0595998 "lives" assertion.
- object C0449900 "contrasting" assertion.
- object C0449788 "numbers" assertion.
- object C0449450 "presented" assertion.
- object C0237881 "significant" assertion.
- object C0237820 "RECOVERY" assertion.
- object C0237753 "numbers" assertion.
- object C0030685 "release" assertion.
- object C0008976 "trial" assertion.
- triple label "The examples of results from trials studying dexamethasone and hydroxychloroquine for treatment of COVID-19 had contrasting outcomes, including the potential for significant numbers of lives saved with the early release of results from the RECOVERY trial studying dexamethasone contrasting with unsubstantiated data being presented from trials studying hydroxychloroquine" assertion.
- sentence label "The examples of results from trials studying dexamethasone and hydroxychloroquine for treatment of COVID-19 have had contrasting outcomes, including the potential for significant numbers of lives saved with the early release of results from the RECOVERY trial studying dexamethasone contrasting with unsubstantiated data being presented from trials studying hydroxychloroquine." assertion.
- version value "1" assertion.
- assertion wasGeneratedBy "S&T TWOC project version 1" assertion.
- Triple-UID select?q=TRIPLE_UID:oj2zt5xw-TRIPLE-ABSTRACT-2 "oj2zt5xw-TRIPLE-ABSTRACT-2" assertion.